Accepted for Publication: May 6, 2021.
Published: July 14, 2021. doi:10.1001/jamanetworkopen.2021.17029
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Mark TL et al. JAMA Network Open.
Corresponding Author: Tami L. Mark, PhD, MBA, RTI International, 6110 Executive Blvd, Ste 900, Rockville, MD 20852 (Tmark@rti.org).
Author Contributions: Dr Joshi had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Mark, Gibbons, Barnosky, Padwa.
Acquisition, analysis, or interpretation of data: Mark, Gibbons, Joshi.
Drafting of the manuscript: Mark, Gibbons, Barnosky, Joshi.
Critical revision of the manuscript for important intellectual content: Mark, Gibbons, Barnosky, Padwa.
Statistical analysis: Mark, Gibbons, Barnosky, Joshi.
Obtained funding: Mark.
Administrative, technical, or material support: Mark, Padwa.
Supervision: Mark.
Conflict of Interest Disclosures: No other disclosures were reported.
Funding/Support: Research reported in this study was funded through a Patient-Centered Outcomes Research Institute award (contract No. HIS-2017C1-6371).
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The results and the conclusions are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or its Methodology Committee.
Additional Contributions: Minerva Reyes and Alicia Van Hoy (California Department of Health Care Services) provided the data in used in this study. They were not compensated for this work.
1.Ahmad
FB , Rossen
LM , Sutton
P . Provisional Drug Overdose Death Counts. National Center for Health Statistics. 2021.
2.Czeisler
MÉ , Lane
RI , Petrosky
E ,
et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(32):1049-1057. doi:
10.15585/mmwr.mm6932a1PubMedGoogle ScholarCrossref 3.Huskamp
HA , Busch
AB , Uscher-Pines
L , Barnett
ML , Riedel
L , Mehrotra
A . Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic.
JAMA. 2020;324(23):2440-2442. doi:
10.1001/jama.2020.21512PubMedGoogle ScholarCrossref 5.Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. US Department of Health and Human Services; 2020.